BSX: Rega marang dodolan Boston Scientific Corp
Boston Scientific is expanding its presence in the cardiology and endoscopy segments driven by an aging population. The P/S ratio history confirms this trend, with the parameter stabilizing at 3.00. Growth is supported by a wide range of implantable devices for global clinics. High plant utilization and the implementation of automated product quality control ensure stability.
Rincian analitis perusahaan Boston Scientific Inc (BSX)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas Boston Scientific|BSX - Utang jangka dawa marang modal|Utang jangka cendhak marang modal Boston Scientific Corporation Inc.|BSX - Utang perusahaan|Rasio utang marang kapitalisasi buku Boston Scientific Inc|BSX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Boston Scientific|Likuiditas darurat bostonscientific.com
- indikator pendapatan resik lan kelipatan nilai:
BSX - Bathi resik perusahaan|Proyeksi bathi resik Boston Scientific|BSX - Koefisien rega marang bathi|Pangali Forward P/E Boston Scientific Corp|BSX - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Boston Scientific Inc|BSX - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Boston Scientific|BSX - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan bostonscientific.com|BSX - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep Boston Scientific
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:bostonscientific.com BSX
Fundamental asset selection requires comparing the market value of a business with actual sales volume to avoid overpaying for inflated expectations. This ratio measures the cost of each unit of revenue, which is critical for Boston Scientific (BSX) amid component logistics disruptions and sanction restrictions; therefore, the current P/S valuation clearly reflects the impact of operational risks on capitalization.
Karo sapa Boston Scientific saingan
Kapitalisasi marang pendapatan edwards.com EW|Multiplikator P/S RMD (ResMed)|Insulet Corp (PODD) - Rega marang dodolan|Zimmer - Multiplikator P/S|COO (CooperSurgical) - Rasio kapitalisasi marang pendapatan|ALGN: Multiplikator P/S|GMED - Koefisien rega marang pendapatan|TMDX (TransMedics Group, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Alphatec Holdings (ATEC)|Multiplikator P/S AORT|Multiplikator P/S Enovis Inc. (ENOV)|Rasio rega marang pendapatan Integra LifeSciences IART|establishmentlabs.com - Rasio rega marang pendapatan|BBNX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IRMD (IRADIMED Corp)|EMBC: Multiplikator P/S|Rega marang dodolan Tandem Corp (TNDM)|Rasio rega marang pendapatan AxoGen, Inc.|SIBN - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan OFIX (Orthofix)|Multiplikator P/S Bioventus Inc (BVS)|Multiplikator P/S KIDS (OrthoPediatrics)|Koefisien rega marang pendapatan Treace Corp (TMCI)|SRTA - Rasio rega marang pendapatan|Rasio rega marang dodolan CARL|RxSight (RXST) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ClearPoint Neuro|STXS (Stereotaxis Corp) - Multiplikator P/S|Rega marang dodolan Neuronetics, Inc STIM|Rasio rega marang pendapatan Sight Sciences, Inc. (SGHT)|orchestrabiomed.com - Rasio kapitalisasi marang pendapatan|Anika Therapeutics, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NSPR (InspireMD Inc)|Jin Medical International Ltd - Multiplikator P/S|VANI: Rasio rega marang pendapatan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|Rega marang dodolan n1mtc.com (NMTC)|Rasio rega marang pendapatan Modular Medical Inc|Myomo Inc. (MYO) - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|Kapitalisasi marang volume dodolan VVOS|Rasio rega marang pendapatan enVVeno Medical NVNO|Sintx Technologies Inc (SINT) - Rega marang dodolan|TNON - Rasio rega marang pendapatan|LFWD (ReWalk Robotics) - Rasio kapitalisasi marang pendapatan|AMIX (autonomix.com) - Kapitalisasi marang pendapatan|INVO Fertility Corp - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Bone Biologics|axonics.com (AXNX) - Koefisien rega marang pendapatan|Multiplikator P/S BIOL|Kapitalisasi marang pendapatan dynatronics.com DYNT|Multiplikator P/S FNA (Paragon 28)|Koefisien rega marang pendapatan INVO Bioscience Inc. (INVO)
